Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
VZ Verizon Communications Inc
HYB New America High Income Fund
MMND Mastermind Inc
FRC First Republic Bank
BXP Boston Properties Inc
ABB Abb Ltd
FNKO Funko Inc
WDH Waterdrop Inc
DGX Quest Diagnostics Inc
Go

Health Care : Pharmaceuticals | Large Cap Growth
Company profile

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups for service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in over 110 countries.

Closing Price
$331.08
Day's Change
-2.52 (-0.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
334.44
Day's Low
328.08
Volume
(Light)
Volume:
3,240,628

10-day average volume:
4,340,444
3,240,628
  • Prev Close
    333.60
  • Today's Open
    334.39
  • Day's Range
    328.08-334.44
  • Avg Vol (10-day)
    4.3M
  • Last (time)
    7:00p ET 03/21/23
  • Last (size)
    3
  • 52-Wk Range
    276.83 - 384.44
    LowHigh
  • (04/25/22 - 01/24/23)
    13.88%
  • 27.1%
  • Market Cap
    315.3B
  • Shares Outstanding
    952.3M
  • 6.91
  • 48.28x
  • $4.52/1.35%
  • Ex-dividend Date
    02/14/23
  • Dividend Pay Date
    03/10/23
  • 0.3
  • 82.68
  • (% of float 02/28/23)
    0.72

Latest News

March 21, 2023
5:06 pm ET
MarketWatch
March 20, 2023
5:07 pm ET
MarketWatch
March 17, 2023
5:06 pm ET
MarketWatch
March 16, 2023
5:07 pm ET
MarketWatch
4:24 pm ET
MarketWatch
March 15, 2023
5:08 pm ET
MarketWatch
March 14, 2023
8:36 pm ET
MarketWatch
4:30 pm ET
PR Newswire
March 13, 2023
5:07 pm ET
MarketWatch
March 10, 2023
5:07 pm ET
MarketWatch
5:20 am ET
Zacks
March 09, 2023
5:07 pm ET
MarketWatch
7:55 am ET
MarketWatch
March 08, 2023
5:07 pm ET
MarketWatch
5:00 pm ET
PR Newswire
9:00 am ET
PR Newswire
7:55 am ET
MarketWatch
March 07, 2023
5:07 pm ET
MarketWatch
March 06, 2023
5:07 pm ET
MarketWatch
10:30 am ET
PR Newswire
March 03, 2023
5:08 pm ET
MarketWatch
2:58 pm ET
PR Newswire
March 02, 2023
5:07 pm ET
MarketWatch
March 01, 2023
5:07 pm ET
MarketWatch
10:08 am ET
MarketWatch
9:31 am ET
PR Newswire
8:04 am ET
MarketWatch
8:03 am ET
MarketWatch
8:03 am ET
MarketWatch
8:00 am ET
PR Newswire
February 28, 2023
5:10 pm ET
MarketWatch
February 27, 2023
5:07 pm ET
MarketWatch
February 24, 2023
5:07 pm ET
MarketWatch
February 23, 2023
5:25 pm ET
MarketWatch
5:06 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.